Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | PPM1B | O75688 | 2/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.31 |
| ▸ | PPP1CC | P36873 | 2/20 | 0.31 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14456348 | 0.85 | ALDH1A1 (0.35) | TP53CYP3A4PPM1BPTPN1PPP1CC | |
| SCHEMBL21919402 | 0.85 | ALDH1A1 (0.35) | TP53CYP3A4PPM1BPTPN1PPP1CC | |
| SCHEMBL16447619 | 0.85 | ALDH1A1 (0.35) | TP53CYP3A4PPM1BPTPN1PPP1CC | |
| SCHEMBL16882717 | 0.85 | ALDH1A1 (0.35) | TP53CYP3A4PPM1BPTPN1PPP1CC | |
| SCHEMBL15554 | 0.85 | ALDH1A1 (0.35) | TP53CYP3A4PPM1BPTPN1PPP1CC | |
| SCHEMBL13075369 | 0.83 | TP53 (0.35) | TP53CYP3A4PPM1BPTPN1PPP1CC | |
| SCHEMBL11714705 | 0.83 | TP53 (0.40) | TP53CYP3A4EPHX1PPM1BPTPN1 | |
| SCHEMBL8506240 | 0.82 | PPM1B (0.33) | TP53CYP3A4PPM1BPTPN1PPP1CC | |
| SCHEMBL9697074 | 0.81 | PPM1B (0.33) | TP53CYP3A4PPM1BPTPN1PPP1CC | |
| SCHEMBL25307194 | 0.80 | TP53 (0.47) | TP53CYP3A4EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 456 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | ADEKA CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4306566-B1 | CURABLE RESIN COMPOSITION, CURED PRODUCT AND ADHESIVE | ADEKA CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12590178-B2 | Curable resin composition and method for suppressing curing shrinkage of curable resin composition | ADEKA CORPORATION (JP) | 2026-03-31 | — | — | US | disclosed |
| US-12584036-B2 | Ink ejection device | Konica Minolta, Inc. (JP) | 2026-03-24 | — | — | US | disclosed |
| EP-3381667-B1 | MOLDING APPARATUS, MANUFACTURING METHOD, AND FIBER-REINFORCED RESIN MATERIAL | ADEKA CORP (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-20260022204-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION CONTAINING SAME, ANTISTATIC RESIN COMPOSITION CONTAINING SAID ANTISTATIC AGENT OR SAID ANTISTATIC AGENT COMPOSITION, AND MOLDED BODY AND FILM THEREOF | ADEKA CORPORATION (JP) | 2026-01-22 | — | — | US | disclosed |
| US-12473472-B2 | Photocurable adhesive | DENSO CORPORATION (JP) | 2025-11-18 | — | — | US | disclosed |
| US-12473470-B2 | Photocurable adhesive | DENSO CORPORATION (JP) | 2025-11-18 | — | — | US | disclosed |
| US-12435176-B2 | Curable resin composition | ADEKA CORPORATION (JP) | 2025-10-07 | — | — | US | disclosed |
| US-12435178-B2 | Resin composition for fiber-reinforced plastic, and fiberreinforced plastic containing said composition | ADEKA CORPORATION (JP) | 2025-10-07 | — | — | US | disclosed |
| US-4448727-A | BLENDED WITH ORGANOPHOSPHITES, EPOXIDES AND CADMIUM, BARIUM AND CERIUM SALTS OF ORGANIC ACIDS | GENERAL ELECTRIC COMPANY (US) | 1984-05-15 | — | — | US | disclosed |
| US-4397973-A | Composition comprising an aromatic polycarbonate and a siloxy-oxyalkylene block copolymer | GENERAL ELECTRIC COMPANY (US) | 1983-08-09 | — | — | US | disclosed |
| US-4221728-A | CHAIN STOPPED POLYORGANOHYDROGENSILOXANE | GENERAL ELECTRIC COMPANY (US) | 1980-09-09 | — | — | US | disclosed |
| US-4197384-A | Stabilized polycarbonate compositions | GENERAL ELECTRIC COMPANY (US) | 1980-04-08 | — | — | US | disclosed |
| US-4118370-A | ESTERIFIED HINDERED PHENOL; MOLDING MATERIALS, FIBERS, LAMINATES | GENERAL ELECTRIC COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
| US-4092288-A | WITH A PHOSPHINE AND AN EPOXY COMPOUND | GENERAL ELECTRIC COMPANY (US) | 1978-05-30 | — | — | US | disclosed |
| US-4076686-A | EPOXY ETHANE OR CYCLOHEXANE COMPOUNDS WITH A PHOSPHITE | GENERAL ELECTRIC COMPANY (US) | 1978-02-28 | — | — | US | disclosed |
| US-4066611-A | CYCLIC DIPHOSPHITE | GENERAL ELECTRIC COMPANY (US) | 1978-01-03 | — | — | US | disclosed |
| US-3978020-A | PHOSPHONITE, EPOXY COMPOUNDS | GENERAL ELECTRIC COMPANY (US) | 1976-08-31 | — | — | US | disclosed |
| US-3953388-A | CONTAINING AN EPOXY COMPOUND AN A PHOSPHINITE | GENERAL ELECTRIC COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | SORD, SUCLA2, SUCLG1 | TP53 4016/4885CYP3A4 2949/4885EPHX1 485/4885 |
| US-20260022204-A1 | ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION CONTAINING SAME, ANTISTATIC RESIN COMPOSITION CONTAINING SAID ANTISTATIC AGENT OR SAID ANTISTATIC AGENT COMPOSITION, AND MOLDED BODY AND FILM THEREOF | PHOSPHO1, EBP, CA1 | TP53 3205/4885CYP3A4 3540/4885EPHX1 109/4885 |
| US-12590178-B2 | Curable resin composition and method for suppressing curing shrinkage of curable resin composition | SEM1, RER1, JMJD6 | TP53 4664/4885CYP3A4 3461/4885EPHX1 1032/4885 |
| US-12584036-B2 | Ink ejection device | ILK, ITGA4, ITGB3 | TP53 1755/4885CYP3A4 3625/4885EPHX1 669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.